ProMedix Inc
Home
About Us
Technology
Publications
Partnerships
Contact
Recent News
ProMedix Inc
Home
About Us
Technology
Publications
Partnerships
Contact
Recent News
More
  • Home
  • About Us
  • Technology
  • Publications
  • Partnerships
  • Contact
  • Recent News
  • Home
  • About Us
  • Technology
  • Publications
  • Partnerships
  • Contact
  • Recent News

ProMedix Headlines

2/2023

12/2022

12/2022

 ProMedix awarded $255,000 Phase 1 STTR (nondilutive grant) from the National Science Foundation. Biz Oregon awards matching grant to support ongoing R&D and technology improvements for patient care.

12/2022

12/2022

12/2022

 After three previous meetings with regulators, ProMedix completes q-sub meeting with FDA; receiving guidance on next steps for completing design validation and safety testing in order to file for 510(k) clearance. FDA approves clinical validation of PeriFRL technology. 

10/2022

12/2022

10/2022

 ProMedix was competitively selected to participate in the Creative Destruction Lab (CDL).  CDL is a global startup program for seed-stage, science-based companies.  


CDL-Vancouver (formerly known as CDL-West) is located in Vancouver, BC at the Sauder School of Business, University of British Columbia. Vancouver is a fast-growing tech hub on the West Coast, combining a Silicon Valley time zone with an Asia-facing outlook. CDL-Vancouver  focuses on the convergence of technologies that improve human health and wellness.  

3/2022

3/2022

10/2022

 ProMedix was competitively selected to receive additional capital investment directly from Baxter’s Innovation Fund and Edward Elmhurst Driven Healthcare Ventures.  

3/2022

3/2022

3/2022

The Journal of Intensive Care Medicine has accepted a manuscript comparing the FlowSense device measurements to manual waveform evaluation. It shows that the device provides accurate, repeatable results that match those of the engineer's manual waveform values.

3/2022

12/2021

12/2021

The American Journal of Emergency medicine has accepted a manuscript detailing the effect of skin tone on CRT measurement using the FlowSense device. The paper shows that the device provides accurate measurements on patients of all skin tones and ethnicities. 

12/2021

12/2021

12/2021

ProMedix has published a review focused on the methods used at the bedside to diagnose sepsis. The focus is centered on comparing CRT versus invasive testing for sepsis diagnosis and highlights the fact that sepsis detection will require multivariable inputs.

10/2021

12/2021

10/2021

ProMedix was accepted as a member of the first MedTech chohort in the competitive mHUB incubation accelerator. 

Learn more

7/2021

12/2020

10/2021

ProMedix has published a manuscript showing that our new point-of-care technology bodes great promise for improving peripheral perfusion assessment. It also investigates the use of the device at the bedside in the emergency department triage area and during active resuscitation.

1/2021

12/2020

12/2020

 ProMedix has received a notice of allowance for our first filed patent (application number 15/405412), where Dr. Steve Baker, Dr. Matthew Hansen and Dr. David Sheridan are all co-inventors.  This patent was developed in a cooperative agreement between OHSU and HillRom (now owned by Baxter), and is exclusively licensed to ProMedix, Inc. 

12/2020

12/2020

12/2020

Promedix has launched a propsective observational study in the ER. Patients will have capillary refill measurements taken with our device in triage and during their resuscitation. The primary objective is to evaluate the ability of our device to improve early sepsis detection. 

11/2020

11/2020

11/2020

ProMedix presented at the highly competitive/peer-reviewed American Heart Association Resuscitation Science Symposium

8/2020

11/2020

11/2020

CTIP, Consortium for Technology and Innovation in Pediatrics, an FDA pediatric device consortium received over 90 applications to their grant competition. Promedix was selected as a winner due to it's ability to improve pediatric sepsis care. 

Learn more

8/2020

11/2020

8/2020

Promedix launched a clinical trial in the adult ICU and inpatient floors to validate their technology in sepsis resuscitation.

5/2020

11/2019

8/2020

Promedix presented research findings at the highly competitive Pediatric Academic Society national meeting.

11/2019

11/2019

11/2019

Promedix received an investment from Ideaship LLC to strategically develop their patent portfolio strategy. Ideaship serves as a trusted advisor as well. 

Learn more

6/2019

11/2019

11/2019

Promedix was an awardee of the highly competitive $100,000 Business Oregon Innovation Grant. 

  • About Us
  • Contact

ProMedix Inc

Copyright © 2025 ProMedix Inc - All Rights Reserved.

Powered by